Repligen
| Use attributes for filter ! | |
| Stock price | RGEN |
|---|---|
| Disclaimer | |
| Revenue | 194 million USD |
| Ceo | Tony J. Hunt |
| Headquarters | Waltham |
| Massachusetts | |
| United States | |
| SVP | Ralf Kuriyel |
| CFO | Jon K. Snodgres |
| Subsidiaries | C Technologies, Inc. |
| Spectrum LifeSciences, LLC | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2416367 |
About Repligen
Repligen is an American company devoted to the development and production of materials used in the manufacture of biological drugs. The company is based in Waltham, Massachusetts, and incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN.
